Skip to main content
Top
Published in: Journal of Translational Medicine 1/2020

Open Access 01-12-2020 | Stroke | Research

Association between telomere length in peripheral blood leukocytes and risk of ischemic stroke in a Han Chinese population: a linear and non-linear Mendelian randomization analysis

Authors: Weijie Cao, Deqiang Zheng, Jie Zhang, Anxin Wang, Di Liu, Jinxia Zhang, Manjot Singh, Isinta Elijah Maranga, Mingyang Cao, Lijuan Wu, Manshu Song, Wei Wang, Youxin Wang

Published in: Journal of Translational Medicine | Issue 1/2020

Login to get access

Abstract

Background

Many contradictory conclusions pertaining to the telomere length in peripheral leukocyte chromosomes as a potential biomarker for ischemic stroke (IS) risk have been reported by the various observational studies in previous years. This study aims to investigate whether the leukocyte telomere length is associated with an increased IS risk or not, based on the Mendelian randomization (MR) approach.

Methods

Based on the NHGRI-EBI GWAS Catalog database, the Chinese online genetic database as well as the previous published studies, twelve single nucleotide polymorphisms (SNPs) with minor allele frequency ≥ 0.05 were selected and the leukocyte telomere length was measured in 431 first-ever IS patients and 304 healthy controls (quantitative polymerase chain reaction). To explore linear and non-linear effect of telomere length on the IS risk, we preformed the linear MR analysis (the inverse-variance weighted method, the maximum likelihood method, and the mode-based estimation method), and the non-linear MR analysis (semiparametric method with three tests for non-linearity, including the quadratic test, Cochran’s Q test, and the fractional polynomial test).

Results

Two verified SNPs (rs11125529 and rs412658) were chosen as instrumental variables. In linear MR analysis, the adjusted odds ratios and 95% confidence intervals of IS for genetically predicted telomere lengths, based on the two SNPs, were 1.312 (0.979 to 1.759), 1.326 (0.932 to 1.888) and 1.226 (0.844 to 1.781) for the inverse-variance weighted method, the maximum likelihood method, and the mode-based estimation method, respectively. Three tests for nonlinearity failed to reject the null exactly, indicating that the relationship between telomere length and IS risk is unlikely to be non-linear.

Conclusion

This MR study based on individual data does not provide strong evidence for a positive linear or non-linear effect of telomere length on the IS risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2018;16:203–12.CrossRef Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2018;16:203–12.CrossRef
2.
go back to reference Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.CrossRef Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.CrossRef
3.
go back to reference Roy-O'Reilly M, McCullough LD. Age and sex are critical factors in ischemic stroke pathology. Endocrinology. 2018;159:3120–31.CrossRef Roy-O'Reilly M, McCullough LD. Age and sex are critical factors in ischemic stroke pathology. Endocrinology. 2018;159:3120–31.CrossRef
4.
go back to reference Camici GG, Savarese G, Akhmedov A, Luscher TF. Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease. Eur Heart J. 2015;36:3392–403.CrossRef Camici GG, Savarese G, Akhmedov A, Luscher TF. Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease. Eur Heart J. 2015;36:3392–403.CrossRef
5.
go back to reference Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35:112–31.CrossRef Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35:112–31.CrossRef
6.
go back to reference Fasching CL. Telomere length measurement as a clinical biomarker of aging and disease. Crit Rev Clin Lab Sci. 2018;55:443–65.CrossRef Fasching CL. Telomere length measurement as a clinical biomarker of aging and disease. Crit Rev Clin Lab Sci. 2018;55:443–65.CrossRef
7.
8.
go back to reference Alzain MA, Asweto CO, Zhang J, Fang H, Zhao Z, Guo X, Song M, Zhou Y, Chang N, Wang Y. Telomere length and accelerated biological aging in the china suboptimal health cohort: a case-control study. Omics. 2017;21:333.CrossRef Alzain MA, Asweto CO, Zhang J, Fang H, Zhao Z, Guo X, Song M, Zhou Y, Chang N, Wang Y. Telomere length and accelerated biological aging in the china suboptimal health cohort: a case-control study. Omics. 2017;21:333.CrossRef
9.
go back to reference Yeh JK, Wang CY. Telomeres and telomerase in cardiovascular diseases. Genes. 2016;7:58.CrossRef Yeh JK, Wang CY. Telomeres and telomerase in cardiovascular diseases. Genes. 2016;7:58.CrossRef
10.
go back to reference Butt HZ, Atturu G, London NJ, Sayers RD, Bown MJ. Telomere length dynamics in vascular disease: a review. Eur J Vasc Endovasc Surg. 2010;40:17–26.CrossRef Butt HZ, Atturu G, London NJ, Sayers RD, Bown MJ. Telomere length dynamics in vascular disease: a review. Eur J Vasc Endovasc Surg. 2010;40:17–26.CrossRef
11.
go back to reference Tian Y, Wang S, Jiao F, Kong Q, Liu C, Wu Y. Telomere length: a potential biomarker for the risk and prognosis of stroke. Front Neurol. 2019;10:624.CrossRef Tian Y, Wang S, Jiao F, Kong Q, Liu C, Wu Y. Telomere length: a potential biomarker for the risk and prognosis of stroke. Front Neurol. 2019;10:624.CrossRef
12.
go back to reference Gao D, Zhang R, Ji G, Li C, Guo D, Jin T, Chen M. Relative telomere length and stroke risk in a chinese han population. J Mol Neurosci. 2018;2018:475–81.CrossRef Gao D, Zhang R, Ji G, Li C, Guo D, Jin T, Chen M. Relative telomere length and stroke risk in a chinese han population. J Mol Neurosci. 2018;2018:475–81.CrossRef
13.
go back to reference Luo D, Hou Q, Yu J, Yu D. Telomere length associated with the risks of high-risk and ischemic stroke in southern Chinese Han population. Oncotarget. 2017;8:105915–22.CrossRef Luo D, Hou Q, Yu J, Yu D. Telomere length associated with the risks of high-risk and ischemic stroke in southern Chinese Han population. Oncotarget. 2017;8:105915–22.CrossRef
14.
go back to reference Ding H, Chen C, Shaffer JR, Liu L, Xu Y, Wang X, Hui R, Wang DW. Telomere length and risk of stroke in Chinese. Stroke. 2012;43:658–63.CrossRef Ding H, Chen C, Shaffer JR, Liu L, Xu Y, Wang X, Hui R, Wang DW. Telomere length and risk of stroke in Chinese. Stroke. 2012;43:658–63.CrossRef
15.
go back to reference Schurks M, Prescott J, Dushkes R, De Vivo I, Rexrode KM. Telomere length and ischaemic stroke in women: a nested case-control study. Eur J Neurol. 2013;20:1068–74.CrossRef Schurks M, Prescott J, Dushkes R, De Vivo I, Rexrode KM. Telomere length and ischaemic stroke in women: a nested case-control study. Eur J Neurol. 2013;20:1068–74.CrossRef
16.
go back to reference Zee RY, Castonguay AJ, Barton NS, Ridker PM. Relative leukocyte telomere length and risk of incident ischemic stroke in men: a prospective, nested case–control approach. Rejuvenation Res. 2010;13:411–4.CrossRef Zee RY, Castonguay AJ, Barton NS, Ridker PM. Relative leukocyte telomere length and risk of incident ischemic stroke in men: a prospective, nested case–control approach. Rejuvenation Res. 2010;13:411–4.CrossRef
17.
go back to reference Ellehoj H, Bendix L, Osler M. Leucocyte telomere length and risk of cardiovascular disease in a cohort of 1397 Danish men and women. Cardiology. 2016;133:173–7.CrossRef Ellehoj H, Bendix L, Osler M. Leucocyte telomere length and risk of cardiovascular disease in a cohort of 1397 Danish men and women. Cardiology. 2016;133:173–7.CrossRef
18.
go back to reference Jin X, Pan B, Dang X, Wu H, Xu D. Relationship between short telomere length and stroke: ameta-analysis. Medicine (Baltimore). 2018;97:e12489.CrossRef Jin X, Pan B, Dang X, Wu H, Xu D. Relationship between short telomere length and stroke: ameta-analysis. Medicine (Baltimore). 2018;97:e12489.CrossRef
19.
go back to reference Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ-BRIT Med J. 2014;349:g4227.CrossRef Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ-BRIT Med J. 2014;349:g4227.CrossRef
20.
go back to reference Sekula P, Del Greco MF, Pattaro C, Kottgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27:3253–65.CrossRef Sekula P, Del Greco MF, Pattaro C, Kottgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27:3253–65.CrossRef
21.
go back to reference Hamad R, Walter S, Rehkopf DH. Telomere length and health outcomes: a two-sample genetic instrumental variables analysis. Exp Gerontol. 2016;82:88–94.CrossRef Hamad R, Walter S, Rehkopf DH. Telomere length and health outcomes: a two-sample genetic instrumental variables analysis. Exp Gerontol. 2016;82:88–94.CrossRef
22.
go back to reference Cao W, Li X, Zhang X, Zhang J, Sun Q, Xu X, Sun M, Tian Q, Li Q, Wang H, et al. No causal effect of telomere length on ischemic stroke and its subtypes: a mendelian randomization study. Cells. 2019;8:159.CrossRef Cao W, Li X, Zhang X, Zhang J, Sun Q, Xu X, Sun M, Tian Q, Li Q, Wang H, et al. No causal effect of telomere length on ischemic stroke and its subtypes: a mendelian randomization study. Cells. 2019;8:159.CrossRef
23.
go back to reference Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, et al. Association between telomere length and risk of cancer and non-neoplastic diseases: a mendelian randomization study. JAMA Oncol. 2017;3:636–51.CrossRef Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, et al. Association between telomere length and risk of cancer and non-neoplastic diseases: a mendelian randomization study. JAMA Oncol. 2017;3:636–51.CrossRef
24.
go back to reference Hernan MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology. 2006;17:360–72.CrossRef Hernan MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology. 2006;17:360–72.CrossRef
25.
go back to reference Staley JR, Burgess S. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization. Genet Epidemiol. 2017;41:341–52.CrossRef Staley JR, Burgess S. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization. Genet Epidemiol. 2017;41:341–52.CrossRef
26.
go back to reference Stroke K. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke. 1989;20:1407–31.CrossRef Stroke K. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke. 1989;20:1407–31.CrossRef
27.
go back to reference Demanelis K, Jasmine F, Chen LS, Chernoff M, Tong L, Delgado D, Zhang C, Shinkle J, Sabarinathan M, Lin H, et al. Determinants of telomere length across human tissues. Science. 2020;369:6876.CrossRef Demanelis K, Jasmine F, Chen LS, Chernoff M, Tong L, Delgado D, Zhang C, Shinkle J, Sabarinathan M, Lin H, et al. Determinants of telomere length across human tissues. Science. 2020;369:6876.CrossRef
28.
go back to reference O'Callaghan NJ, Fenech M. A quantitative PCR method for measuring absolute telomere length. Biol Proced Online. 2011;13:3.CrossRef O'Callaghan NJ, Fenech M. A quantitative PCR method for measuring absolute telomere length. Biol Proced Online. 2011;13:3.CrossRef
29.
go back to reference O'Callaghan N, Dhillon V, Thomas P, Fenech M. A quantitative real-time PCR method for absolute telomere length. Biotechniques. 2008;44:807–9.CrossRef O'Callaghan N, Dhillon V, Thomas P, Fenech M. A quantitative real-time PCR method for absolute telomere length. Biotechniques. 2008;44:807–9.CrossRef
30.
go back to reference Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Hardikar S, Aviv A. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2011;66:421–9.CrossRef Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Hardikar S, Aviv A. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2011;66:421–9.CrossRef
31.
go back to reference Weischer M, Bojesen SE, Nordestgaard BG. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4576 general population individuals with repeat measurements 10 years apart. PLoS Genet. 2014;10:e1004191.CrossRef Weischer M, Bojesen SE, Nordestgaard BG. Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4576 general population individuals with repeat measurements 10 years apart. PLoS Genet. 2014;10:e1004191.CrossRef
32.
go back to reference Jiang X, Dong M, Cheng J, Huang S, He Y, Ma K, Tang B, Guo Y. Decreased leukocyte telomere length (LTL) is associated with stroke but unlikely to be causative. PLoS ONE. 2013;8:e68254.CrossRef Jiang X, Dong M, Cheng J, Huang S, He Y, Ma K, Tang B, Guo Y. Decreased leukocyte telomere length (LTL) is associated with stroke but unlikely to be causative. PLoS ONE. 2013;8:e68254.CrossRef
33.
go back to reference Li J, Feng C, Li L, Yang S, Chen Y, Hui R, Zhang M, Zhang W. The association of telomere attrition with first-onset stroke in Southern Chinese: a case–control study and meta-analysis. Sci Rep. 2018;8:2290.CrossRef Li J, Feng C, Li L, Yang S, Chen Y, Hui R, Zhang M, Zhang W. The association of telomere attrition with first-onset stroke in Southern Chinese: a case–control study and meta-analysis. Sci Rep. 2018;8:2290.CrossRef
34.
go back to reference D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Pare G. Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis. Circ-Cardiovasc Genet. 2015;8:82–90.CrossRef D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Pare G. Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis. Circ-Cardiovasc Genet. 2015;8:82–90.CrossRef
35.
go back to reference Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ-BRIT Med J. 2018;362:k601.CrossRef Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ-BRIT Med J. 2018;362:k601.CrossRef
36.
go back to reference Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89–98.CrossRef Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89–98.CrossRef
37.
go back to reference Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42:1497–501.CrossRef Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42:1497–501.CrossRef
Metadata
Title
Association between telomere length in peripheral blood leukocytes and risk of ischemic stroke in a Han Chinese population: a linear and non-linear Mendelian randomization analysis
Authors
Weijie Cao
Deqiang Zheng
Jie Zhang
Anxin Wang
Di Liu
Jinxia Zhang
Manjot Singh
Isinta Elijah Maranga
Mingyang Cao
Lijuan Wu
Manshu Song
Wei Wang
Youxin Wang
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Stroke
Biomarkers
Published in
Journal of Translational Medicine / Issue 1/2020
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-020-02551-1

Other articles of this Issue 1/2020

Journal of Translational Medicine 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine